Home
NICE Guidance
Conditions and diseases
Cancer
Breast cancer
Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer
Technology appraisal guidance [TA214]
Published:
23 February 2011
Guidance
Tools and resources
Information for the public
History
Do no do examples
Do no do examples for Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer
Title
Year published
Impact Level
No results could be found